Assessment and management of Heart Failure in Patients with Chronic Kidney Disease

CKD in HF patients is very common condition, their dysfunction is closely linked and influence each other, so their management required multidisciplinary and personalized approaches. The diagnosis of HF and CDK relies on signs and symptoms. Several tools, such as blood-based biomarkers and echography help us to clarify and discriminate the main characteristics of these patients. Evidence in improving survival due to new drug-employment in HF, has increasingly challenged physicians to manage patients with multiple diseases, especially in patients with CKD. The difficulty is in the safe administration of these drugs in patients with HF and CKD. Knowing up to which values ​​of creatinine or renal clearance any drug can be administered is fundamental. We wanted to summarize, on this sizable and complex topic, the experiences of various prior study to get clearer ideas and a more precise reference about the assessment and management of HF and CKD..

Medienart:

Preprint

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Preprints.org - (2024) vom: 29. März Zur Gesamtaufnahme - year:2024

Sprache:

Englisch

Beteiligte Personen:

Guaricci, Andrea Igoren [VerfasserIn]
Sturdà, Francesca [VerfasserIn]
Russo, Roberto [VerfasserIn]
Basile, Paolo [VerfasserIn]
Baggiano, Andrea [VerfasserIn]
Mushtaq, Saima [VerfasserIn]
Fusini, Laura [VerfasserIn]
Fazzari, Fabio [VerfasserIn]
Bertrandino, Fulvio [VerfasserIn]
Monitillo, Francesco [VerfasserIn]
Carella, Maria Cristina [VerfasserIn]
Simonini, Marco [VerfasserIn]
Pontone, Gianluca [VerfasserIn]
Ciccone, Marco Matteo [VerfasserIn]
Grandaliano, Giuseppe [VerfasserIn]
Vezzoli, Giuseppe [VerfasserIn]
Pesce, Francesco [VerfasserIn]

Links:

Volltext [lizenzpflichtig]
Volltext [kostenfrei]

doi:

10.20944/preprints202304.0422.v1

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

preprintsorg039298116